{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Deerfield",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "BLA208157"
        ],
        "brand_name": [
          "MYXREDLIN"
        ],
        "generic_name": [
          "INSULIN HUMAN"
        ],
        "manufacturer_name": [
          "Baxter Healthcare Corporation"
        ],
        "product_ndc": [
          "0338-0126"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "INSULIN HUMAN"
        ],
        "rxcui": [
          "2179744",
          "2179749"
        ],
        "spl_id": [
          "9642c441-5143-410a-af83-db5daded5420"
        ],
        "spl_set_id": [
          "afca6e80-a802-49fb-a978-5fe28a173001"
        ],
        "package_ndc": [
          "0338-0126-12"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "M0011417",
          "N0000175944"
        ],
        "pharm_class_cs": [
          "Insulin [CS]"
        ],
        "pharm_class_epc": [
          "Insulin [EPC]"
        ],
        "unii": [
          "1Y17CTI5SR"
        ]
      },
      "product_type": "Drugs",
      "event_id": "99500",
      "recalling_firm": "Baxter Healthcare Corporation",
      "address_1": "1 Baxter Pkwy",
      "address_2": "N/A",
      "postal_code": "60015-4625",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide; Puerto Rico; and Chile.",
      "recall_number": "D-0806-2026",
      "product_description": "MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.",
      "product_quantity": "N/A",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20260806",
      "center_classification_date": "20260828",
      "report_date": "20260909",
      "code_info": "Lot # NC188630, NC188708, NC188791, NC188845, NC188876, NC188968, Exp Date: 12/31/2027; Lot # NC193719, NC193849, Exp Date: 04/30/2028; Lot # NC194051, NC194105, Exp Date: 05/31/2028; Lot # NC195171, Exp Date: 06/30/2028.",
      "more_code_info": ""
    }
  ]
}